Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Multiple retinal vein thromboses after intravitreal aflibercept injections for age-related macular degeneration.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE
    • بيانات النشر:
      Publication: Oxford, UK : Wiley-Blackwell
      Original Publication: Oxford, UK ; Malden, MA : Blackwell Munksgaard
    • الموضوع:
      Angiogenesis Inhibitors/*adverse effects ; Macular Degeneration/*drug therapy ; Recombinant Fusion Proteins/*adverse effects ; Retinal Vein Occlusion/*chemically induced; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Female ; Humans ; Intravitreal Injections/adverse effects ; Male ; Receptors, Vascular Endothelial Growth Factor/administration & dosage ; Recombinant Fusion Proteins/administration & dosage
    • References:
      Muraoka Y, Tsujikawa A, Murakami T, Ogino K, Kumagai K, Miyamoto K, Uji A & Yoshimura N (2013): Morphologic and functional changes in retinal vessels associated with branch retinal vein occlusion. Ophthalmology 120: 91-99.
      Nomura Y, Kaneko M, Miyata K, Yatomi Y & Yanagi Y (2015): Bevacizumab and aflibercept activate platelets via FcγRIIa. Invest Ophthalmol Vis Sci 56: 8075-8082.
      Papadopoulos N, Martin J, Ruan Q et al. (2012): Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 15: 171-185.
      Van Cutsem E, Tabernero J, Lakomy R et al. (2012): Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol 30: 3499-3506.
      Verheul HM & Pinedo HM (2007): Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Nat Rev Cancer 7: 475-485.
    • Grant Information:
      Santen/Bayer; Novartis Pharma
    • الرقم المعرف:
      0 (Angiogenesis Inhibitors)
      0 (Recombinant Fusion Proteins)
      15C2VL427D (aflibercept)
      EC 2.7.10.1 (Receptors, Vascular Endothelial Growth Factor)
    • الموضوع:
      Date Created: 20200117 Date Completed: 20210302 Latest Revision: 20210302
    • الموضوع:
      20231215
    • الرقم المعرف:
      10.1111/aos.14345
    • الرقم المعرف:
      31943800